Lannett Aktie

Lannett für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 882871 / ISIN: US5160121019

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
21.10.2016 17:10:00

Mallinckrodt plc -- Moody's: FDA Proposal to withdraw generic Concerta from the market would be negative for Lannett and Mallinckrodt

New York, October 21, 2016 -- Moody's Investors Service commented that the Food and Drug Administration's (FDA) proposal to withdraw approval of the Abbreviated New Drug Applications (ANDAs) for methylphenidate HCl ER tablets (the generic version of Concerta) is credit negative for Mallinckrodt International Finance SA (Ba3 stable) and Lannett Company Inc. (B2 stable). There is no change to either company's rating or outlook.

Vollständigen Artikel bei Moodys lesen